Fig 1.
A flowchart depicting the timeline of upfront chemotherapy and short-course radiotherapy with delayed surgery at our institution.
Table 1.
Patient characteristics.
Table 2.
Pathology reports (n = 44).
Table 3.
Surgical pathology for primary tumor, residual tumor status, and patterns of failure based on treatment groups.
Fig 2.
Kaplan-Meier curves according to treatment groups.
(a) The progression-free survival rates of the curable (broken line) and potentially curable (line) groups were significantly longer than that of the palliative group (dotted line). (b) The curable (broken line) and potentially curable (line) groups showed longer overall survival than the palliative group (dotted line).
Table 4.
Stepwise uni- and multi-variate analysis using cox regression model for progression-free and overall survival.
Table 5.
Treatment-related toxicity.